Oblique Therapeutics is delighted to announce the appointment of Christer Nordstedt M.D. PhD. as Chief Executive Officer

/PRNewswire/ -- Oblique Therapeutics AB (publ.), a biotechnology company focused on new antibody medicines for severe diseases with large unmet medical needs,...

Related Keywords

Sweden ,Uppsala ,Uppsala Lan ,Gothenburg ,Vastra Gotalands Lan ,Swedish ,Karolinska Institutet ,Mats Jonasson ,Hans Peter Ostler ,Kjell Andersson ,Eli Lilly ,Marie Scherlund ,Christer Nordstedt ,Sreeshap Srinivasa ,Astrazeneca ,Management Team At Oblique Therapeutics ,Orion Corporation ,Teva Pharmaceuticals ,Chief Executive Officer ,Oblique Therapeutics ,Management Team ,Carolina Trkulja ,Phd Chief Technical Officer ,Medicinal Chemistry ,Chief Development Officer ,Chief Financial Officer ,Chief Program Officer ,Chief Business Officer ,Cecilia Larsson ,Investor Relations Manager ,Owe Orwar ,Chief Scientist Officer ,Advances Publication ,Business Officer ,Oblique Therapeutics Ab ,